Omada Health, Inc.

Omada Health, Inc. is a digital healthcare company established in 2011, dedicated to providing virtual-first care solutions for the prevention and management of chronic conditions. The company's mission is to empower individuals to achieve lasting health changes through personalized, evidence-based programs. Headquartered in San Francisco, California, Omada Health leverages technology to deliver comprehensive health and well-being services.

The company offers a range of virtual care programs addressing conditions such as prediabetes, type 2 diabetes, hypertension, musculoskeletal issues, and weight management, including specialized support for members utilizing GLP-1 medications. These programs integrate behavioral science, professional health coaching, and connected devices like smart scales, blood pressure cuffs, glucose monitors, and continuous glucose monitors (CGMs) to facilitate remote monitoring and personalized guidance. Omada Health primarily operates through a business-to-business-to-consumer (B2B2C) model, partnering with employers, health plans, health systems, and pharmacy benefit managers to deliver its services to their members.

Omada Health became a publicly traded company on June 6, 2025, listing on Nasdaq under the ticker symbol OMDA. Sean Duffy co-founded the company in 2011 and serves as its Chief Executive Officer. The company has garnered recognition for its evidence-based solutions, having surpassed 1 million lifetime members and serving over 2,000 enterprise customers. Recent developments include studies demonstrating the efficacy of its GLP-1 companion programs, the announcement of its Q4 2025 financial results, and the expansion of its integrated platform to include cholesterol care.